Calidi Biotherapeutics (CLDI) Depreciation and Depletion (2022 - 2025)
Calidi Biotherapeutics' quarterly Depreciation and Depletion came in at $91000.0 in Q1 2025, down 9.0% year-on-year from $100000.0 in Q1 2024, and down 10.78% quarter-over-quarter from $102000.0 in Q4 2024.
Calidi Biotherapeutics has reported Depreciation and Depletion for 4 years, with the latest figure at $91000.0 in Q1 2025.
- For the quarter ending Q1 2025, Depreciation and Depletion fell 9.0% year-over-year to $91000.0; the trailing twelve-month figure through Mar 2025 stood at $393000.0 (down 1.5% YoY), and the FY2024 full-year result was $402000.0, up 2.55% from the prior year.
- Depreciation and Depletion for Q1 2025 stood at $91000.0, down from $102000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $102000.0 in Q4 2024, with the low at $91000.0 in Q1 2025.
- Average Depreciation and Depletion over 4 years is $99272.7, with a median of $100000.0 recorded in 2022.
- Year-over-year, Depreciation and Depletion gained 3.03% in 2024 and retreated 9.0% in 2025.
- Tracing CLDI's Depreciation and Depletion over 4 years: stood at $100000.0 in 2022, then decreased by 1.0% to $99000.0 in 2023, then climbed by 3.03% to $102000.0 in 2024, then decreased by 10.78% to $91000.0 in 2025.
- The last three Depreciation and Depletion figures came in at $91000.0 (Q1 2025), $102000.0 (Q4 2024), and $100000.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | - |
| 10 | Calidi Biotherapeutics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 91,000.00 |
| Mar 31, 2025 | 91,000.00 |
| Dec 31, 2024 | 102,000.00 |
| Dec 31, 2024 | 102,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Sep 30, 2022 | 100,000.00 |